Modulators of protein tyrosine phosphatases
CA 2323472 A1 · Owner: Jeppesen, Lone · Inventors: Uyeda, Roy Teruyuki; Ge, Yu; Andersen, Henrik Sune
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention provides novel compounds novel compositions, methods of , their use and methods of their manufacture, where such compounds are pharmacologically useful inhibitors of Protein Tyrosine Phosphatases (PTPases PTPs) such as PTP1B, TC-PTP, CD45, SHP-1 SHP-2, PTP.alpha. PTP.epsilon. PTPµ, PTP.delta. PTP.sigma. PTP PTP.beta. PTPD1, PTPD2, PTPH1, PTP-, MEG1 PTP-LAR, and HePTP. These compounds are indicated in the management or treatment of a broad range of diseases such as autoimmune diseases acute and , chronic inflammation, osteoporosis various forms of cancer and malignant diseases, and type I diabetes and type II diabetes.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed March 12, 1999. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended March 12, 2019.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by March 12, 2021.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.